Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most prevalent non-small cell lung cancer (NSCLC). Patients with LUAD have a poor 5-year survival rate. The use of immune checkpoint inhibitors (ICIs) for the treatment of LUAD has been on the rise in the past decade. This study explored the prognostic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Weishuang, Liang, Jiaming, Mo, Junjian, Zhang, Siyuan, Hu, Ningdong, Tian, Dongbo, Chen, Zisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507344/
https://www.ncbi.nlm.nih.gov/pubmed/34635082
http://dx.doi.org/10.1186/s12885-021-08790-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507344/
https://www.ncbi.nlm.nih.gov/pubmed/34635082
http://dx.doi.org/10.1186/s12885-021-08790-9

Ejemplares similares